oxaprozin
Generic: oxaprozin
Labeler: ayurax, llcDrug Facts
Product Profile
Brand Name
oxaprozin
Generic Name
oxaprozin
Labeler
ayurax, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
oxaprozin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
73308-403
Product ID
73308-403_bcd6546b-09dc-4d44-9a4c-8e6d36891c67
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA217927
Listing Expiration
2026-12-31
Marketing Start
2023-11-14
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
73308403
Hyphenated Format
73308-403
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxaprozin (source: ndc)
Generic Name
oxaprozin (source: ndc)
Application Number
NDA217927 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 60 CAPSULE in 1 BOTTLE (73308-403-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bcd6546b-09dc-4d44-9a4c-8e6d36891c67", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["2668162"], "spl_set_id": ["75482b79-38b0-4765-af3e-726b7ad38b90"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Ayurax, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (73308-403-60)", "package_ndc": "73308-403-60", "marketing_start_date": "20231114"}], "brand_name": "Oxaprozin", "product_id": "73308-403_bcd6546b-09dc-4d44-9a4c-8e6d36891c67", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "73308-403", "generic_name": "oxaprozin", "labeler_name": "Ayurax, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "300 mg/1"}], "application_number": "NDA217927", "marketing_category": "NDA", "marketing_start_date": "20231114", "listing_expiration_date": "20261231"}